GenmabGMAB 
$20.47-1.40%24h
-1.40%24h
Global rank1179
Market cap$13.37B
Change 7d2.66%
YTD Performance-
SP500 benchmark
P/E3.10
P/S5.83
Revenue$2.29B
Earnings$606.17M
Dividend yield-
Main Sector
Healthcare
EPS for Genmab (GMAB)
Genmab has an EPS of $6.602. In 2022, the company made an earnings per share (EPS) of $8.259. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for GMAB
-
Value:-
EPS history for Genmab from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | $6.60 | -20.06% |
| 2022 | $8.26 | 84.48% |
| 2021 | $4.48 | -38.00% |
| 2020 | $7.22 | - |
View the highest EPS stocks
